NCT03339765

Brief Summary

Self-advocacy, defined as the ability of a patient to get her needs and priorities met in the face of a challenge, is an essential skill but not all women with advanced cancer are able to do it. We want to instruct women with advanced cancer who have low self-advocacy to self-advocate for their health and well-being. We will test a new "serious game" or video program that teaches self-advocacy skills through interactive, situation-based activities. The goal of the Strong Together serious game is to engage participants in challenges commonly experienced by women with advanced cancer, offer them choices to self-advocate or not, and directly show them the health and social benefits of self-advocating and the negative consequences of not self-advocating. Through engaging in the Strong Together program, participants vicariously learn the essential skills of self-advocacy, understand the downstream effects of using or not using these skills, and learn distinct behaviors that they can then use to address their own challenges.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 3, 2017

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 13, 2017

Completed
1.1 years until next milestone

Study Start

First participant enrolled

December 13, 2018

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 18, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 18, 2021

Completed
Last Updated

July 5, 2023

Status Verified

July 1, 2023

Enrollment Period

2.3 years

First QC Date

November 3, 2017

Last Update Submit

July 3, 2023

Conditions

Keywords

Self-advocacyAdvanced cancerSerious gamesSelf-management

Outcome Measures

Primary Outcomes (2)

  • Number of participants who engage in at least 8 out of the 12 serious game sessions

    We will calculate the number of participants in the intervention group who complete two-thirds (66.7%) of the intervention sessions as a measure of intervention feasibility. We will accept that we achieved adequate feasibility if at least 75% of participants engage in at least eight out of the twelve serious game sessions.

    3 months

  • Number of participants who find the intervention acceptable based on ratings of the Post Study System Usability Questionnaire and qualitative interviews.

    We will accept that we achieved adequate acceptability if at least 80% of participants find the intervention acceptable based on the Post Study System Usability Questionnaire scores and if no issues are raised during the qualitative interviews and feedback that cannot be revised prior to the future trial.

    3 months

Secondary Outcomes (4)

  • Change in patient self-advocacy as assessed by the Female Self-Advocacy in Cancer Survivorship Scale.

    Baseline, 3 months, and 6 months

  • Change in symptom burden as assessed by the MD Anderson Symptom Inventory scale.

    Baseline, 3 months, and 6 months

  • Change in healthcare utilization as assessed by participants' number of hospital admissions, emergency room visits, and primary care visits in the past three months.

    Baseline, 3 months, and 6 months

  • Change in quality of life as assessed by the Functional Assessment of Cancer Therapy-General scale.

    Baseline, 3 months, and 6 months

Study Arms (2)

Serious game intervention

EXPERIMENTAL

Participants randomized to the intervention will receive the Strong Together serious game program on a tablet computer. The goal of this serious game is to teach the participant how to advocate for her needs relate to her cancer and treatment. The research team will send participants weekly notifications for 12 weeks to alert them that a new serious game session is available and encourage them to complete one session per week.

Behavioral: Strong Together serious game

Enhanced care as usual

NO INTERVENTION

If randomized to the enhanced care as usual arm, the research team will give participants a paper-based self-advocacy patient brochure published by the National Coalition for Cancer Survivorship. This guide is not a part of usual care, but is freely available on the Internet.

Interventions

The Strong Together serious game program is an interactive, immersive education program in which participants quickly learn the behaviors of self-advocacy and the potential consequences of self-advocating or not. Participants will receive weekly game sessions to play at home for three months.

Serious game intervention

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsInclusion criteria are based on cancer diagnoses which primarily occur in women (gynecological and breast cancer).
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female
  • ≥18 years
  • Diagnosed with Stage III or IV gynecological or Stage IV breast cancer within the past 3 months being treated with non-curative intent
  • Have at least a 6-month life expectancy (as determined by their oncologist)
  • Eastern Cooperative Oncology Group performance score of 0 to 2 (per health record or oncologist)
  • Able to read and write in English

You may not qualify if:

  • On hospice at the time of recruitment
  • Impaired cognition (per health record)
  • Other active, unstable mental health disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15261, United States

Location

MeSH Terms

Conditions

Ovarian NeoplasmsBreast NeoplasmsUterine Cervical NeoplasmsEndometrial NeoplasmsVulvar NeoplasmsVaginal Neoplasms

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesEndocrine System DiseasesGonadal DisordersBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesUterine NeoplasmsUterine Cervical DiseasesUterine DiseasesVulvar DiseasesVaginal Diseases

Study Officials

  • Teresa H Thomas, PhD, RN

    University of Pittsburgh School of Nursing

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 3, 2017

First Posted

November 13, 2017

Study Start

December 13, 2018

Primary Completion

March 18, 2021

Study Completion

March 18, 2021

Last Updated

July 5, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations